Curevo Vaccine
- David Miller
David Miller
Senior Director, Strategic Communications at Curevo Vaccine
A former biotech analyst, David has 20+ years of experience with business strategy, communications, and business analysis focusing on technology and biotechnology industries. He led the investor relations and communications program at Angion (NASDAQ:ANGN), helping take the company public via a 2021 IPO. He held a variety of roles at Alpine Immune Sciences (NASDAQ:ALPN), helping taking the company public via a reverse merger in 2017.
Timeline
Senior Director, Strategic Communications
Current role
Related people
Jennifer Malin
Senior Director, Strategic Communications at Community Foundation Tampa Bay
Diana El Azar
Senior Director, Strategic Communications at Minerva Project
Breanna Bishop
Senior Director, Strategic Communications at Lawrence Livermore National Laboratory
Mayu Mishina
Senior Director, Strategic Communications at Tanager
Katie Mongue
Senior Director, Strategic Communications at Portland Metro Chamber